Robotic lobectomy is the main thoracic procedure performed for oncological reasons, which has been rapidly evolving over this last decade, considering improved surgical techniques and enhanced technology systems. Operative indications are nowadays commonly extended for this technology considering the surgical technique, patient clinical stage and history. The procedure has rapidly been considered as effective as VATS and superior to thoracotomy, allowing significant reduction of the adverse perioperative and postoperative events. It has recently been cited by large systematic reviews as superior to VATS. Oncological operative radically, that mainly considers the completeness of lymph node resection and the nodal upstaging, and the survival outcomes have been confirmed to be similar to those of the open and VATS procedures. Postoperative quality of life and pain management evaluations as well as pulmonary recovery testing have shown superiority to open techniques and equivalence to VATS. Debates are still active over costs, seeing intra and postoperative respective implications, with a net economic effect that seems positive over open techniques.
Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://misjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mis
Submission Deadline: 31 Jul 2019
Contacts: Jane Ke, Assistant Editor, firstname.lastname@example.org